Treace Medical Concepts, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $4.44
- 52-Week Range
- $1.17 – $5.44
- Market Cap
- $296.98M
- P/E (TTM)
- —
- EPS (TTM)
- -0.85
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 4.81
- PEG Ratio
- —
- Return on Equity
- -73.98%
- Return on Assets
- -16.49%
- Gross Margin
- 79.55%
- Operating Margin
- -24.38%
- Profit Margin
- -27.44%
- Current Ratio
- 2.58
- Debt/Equity
- 1.21
- Total Debt
- $74.84M
- Free Cash Flow
- $-2.37M
- Revenue Growth
- -3.90%
- Earnings Growth
- —
- Enterprise Value
- $332.03M
Market Snapshot
About
Treace Medical Concepts, Inc. is a medical technology company focused on advancing the standard of care for the surgical management of bunion deformities. The company has developed the Lapiplasty 3D Bunion Correction system, a proprietary procedure and instrumentation platform.